Achiko’s Commercialization Update: Optimized Second-Generation Covid-19 Diagnostic Test Receives Full Product Registration Approval in Indonesia
08 déc. 2021 07h50 HE
|
Achiko AG
Second-generation of AptameX, Achiko’s innovative DNA aptamer diagnostic test for Covid-19 has received full approval in Indonesia for five yearsProduction of the second-generation AptameX kits to...
Achiko Secures Initial Sales of AptameX Covid-19 Diagnostic Test
27 oct. 2021 07h30 HE
|
Achiko AG
Achiko has received its first purchase order in Jakarta and Bali in Indonesia.The orders translate to 20,000 tests - while modest in size, the order is expected to pave the way to rapid adoption by...
Market Outlook and Production Plan Update for AptameX
20 oct. 2021 07h30 HE
|
Achiko AG
After receiving product and registration approval from Indonesia’s Ministry of Health in August, Achiko is positioned to produce up to a million AptameX test kits in Q4 2021, and more if the supply...
Achiko Launches Covid-19 Testing Pilot Program in Indonesia
07 oct. 2021 07h30 HE
|
Achiko AG
Launch of pilot program in Indonesia for Achiko’s proprietary, low-cost rapid Covid-19 diagnostic test, AptameX, alongside its sister digital passporting service, Teman Sehat (“Health Buddy”).Purpose...
Achiko Engages EpiMetrics to Expand Covid-19 Testing Operations with Udayana University in Bali, Indonesia in the Implementation of a Mass Testing Program
15 juil. 2021 07h30 HE
|
Achiko AG
ZURICH, Switzerland, July 15, 2021 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), a global healthtech company...
Achiko Working Towards a Solution for Frequent Global Mass COVID-19 Testing
13 juil. 2021 07h30 HE
|
Achiko AG
ZURICH, Switzerland, July 13, 2021 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), a global healthtech company currently developing technologies that seek to...
Achiko Announces an Extension of its Convertible Loan Transaction with Negma Group
18 juin 2021 12h01 HE
|
Achiko AG
ZURICH, June 18, 2021 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”) has successfully extended the subordinated convertible loan agreement of CHF 900,000 dated...
Achiko Announces the Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-19 Diagnostic Testing Platform for Launch in Indonesia
03 juin 2021 07h30 HE
|
Achiko AG
Wireless integration of AptameX Covid-19 test with Teman Sehat completedTeman Sehat’s open API allows for integration of third party testing platformsTeman Sehat provides results within 15 minutes,...
Achiko AG Announces Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-19 Diagnostic Testing Platform for Launch in Indonesia
03 juin 2021 00h45 HE
|
Achiko AG
Wireless Integration of AptameX Covid-19 Test with Teman Sehat CompletedTeman Sehat’s Open API Allows for Integration of Third Party Testing PlatformsTeman Sehat Provides Results within 15 minutes,...
Achiko Completes Initial Shipment of AptameX, its Progressive Covid-19 Diagnostic Test to Indonesia, Delivering 77% Sensitivity at Low Viral Loads
20 mai 2021 07h30 HE
|
Achiko AG
Production of First 1,000 AptameX Test Kits is Concluded in Singapore (initial capacity to test 10,000 patients per day).AptameX Delivers Sensitivity of 77% (95% CI: 75.94 - 79.24) at a High Industry...